Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15
Senescence protects damaged cells from neoplastic transformation by inducing a stable growth arrest 1, 2 . Concomitant with this arrest, cells secrete a complex mixture of factors referred to as the SASP or senescence-messaging secretome 3, 4 . The SASP can exert opposing and contradictory effects 4 . Initial studies focused on the pro-tumorigenic properties of the SASP (refs 5-7) but the SASP also mediates important tumour suppressive effects 3 . Specific components of the SASP such as IGFBP-7, PAI-1, IL-6 and CXCR2-binding chemokines (such as IL-8 or GROα) can reinforce senescence [8] [9] [10] [11] . The SASP also contributes to the surveillance and elimination of senescent cells by the immune system [12] [13] [14] . It is unclear whether pro-senescence effects can be exerted in a noncell-autonomous fashion (paracrine) in addition to a cell-autonomous fashion (autocrine) and whether senescence can be transmitted to normal cells. Early experiments where young and old fibroblasts were mixed suggested that senescence was exclusively cell intrinsic 15, 16 although more recently a bystander senescence response has been suggested 17 . However, although some factors secreted by senescent cells, such as IL-6, reinforce senescence in an intracrine fashion 9 , others such as IGFBP-7 can exhibit paracrine effects 11 . In this investigation, we present unequivocal evidence supporting that senescence can be transmitted in a paracrine fashion, and provide insights into the pathways regulating and mediating paracrine senescence.
RESULTS

Paracrine transmission of senescence by cells undergoing OIS
To understand whether cells undergoing OIS can transmit senescence in a non-cell-autonomous manner, we established co-cultures of senescent and normal human IMR90 fibroblasts. Cells were distinguished by expressing an mCherry fluorescent marker (Cherry) in the normal IMR90 cells. The Cherry-positive and -negative populations were monitored using high content analysis microscopy ( Fig. 1a and Supplementary Fig. S1a,b) . We used IMR90 ER:RAS cells expressing a chimaeric fusion protein that activates on treatment with 4-hydroxytamoxifen (4OHT). RAS activation triggers growth arrest, and induces senescence effectors and the SASP (Supplementary Fig.  S2a ). IMR90-ER:RAS cells co-cultured with normal IMR90 Cherry cells also undergo arrest on 4OHT treatment (Fig. 1a, middle) .
Importantly, normal IMR90 Cherry cells also stopped proliferating when co-cultured with cells undergoing OIS, which suggested a noncell-autonomous (paracrine) transmission of senescence (Fig. 1a, right  panel) . Controls confirmed that Cherry-positive cells did not express ER:RAS ( Supplementary Fig. S2b ). Normal IMR90 Cherry cells also underwent arrest when co-cultured with IMR90 MEK:ER cells (Fig. 1b) , ER:RAS cells grown 7 days in the presence 200 nM 4OHT. The effect of CM on IMR90 cells was evaluated by BrdU staining (bottom). Data are for a representative experiment of n = 2 independent experiments for days 1-3 and mean ± s.d. of n = 3 independent experiments for day 4. The source data for two independent experiments and statistics for day 4 (Student's t -test) are provided in Supplementary Table S8 an alternative model of OIS (Supplementary Fig. S2c) . Expression of the ER-binding domain alone, or treatment with 4OHT, did not affect the growth of IMR90 ER cells or IMR90 Cherry cells co-cultured with them ( Fig. 1c and Supplementary Fig. S2d ). These experiments were performed using early passage IMR90 cells ( Supplementary Fig.  S2e ) to exclude confounding effects of replicative senescence. Normal human mammary epithelial cells (HMECs) also underwent arrest on co-culture with HMECs undergoing OIS (HMEC ER:RAS, Fig. 1d centre and Supplementary Fig. S2f ). Moreover, HMEC ER:RAS cells induced the arrest of normal IMR90 fibroblasts ( Fig. 1d right and Supplementary Fig. S2g ), suggesting that paracrine senescence can be transmitted between different cell types. These results clearly show that senescence can be transmitted.
Paracrine senescence is a stable arrest mediated by secreted factors
We noted that normal cells arrested with a slight delay when compared with cells undergoing OIS in co-cultures (Fig. 2a) . We reasoned that this delay could be attributed to a paracrine response, as the induction of SASP components (CXCL1, IL-8, CCL-20, activin A or VEGFc) occurred as early as 2-3 days after RAS activation ( Fig. 2b and Supplementary Fig. S3a ).
To investigate whether soluble factors mediate paracrine senescence, we used Transwell inserts that ensure physical separation of the cells (Fig. 2c and Supplementary Fig. S3b ). IMR90 cells at the bottom exhibited a senescent morphology and became arrested when co-cultured in the presence of senescent cells in the top chamber ( Supplementary  Fig. S3b ). Next, we co-cultured normal cells and IMR90 ER:RAS for 7 days using Transwells. At that point we split the IMR90 cells, and cultured them alone for 14 another days (Fig. 2c) . Cells that have undergone paracrine senescence continued exhibiting features of senescence, suggesting that the transmitted phenotype is stable (Fig. 2c) . Analysis using quantitative PCR with reverse transcription (qRT-PCR) discarded cross-contamination between cells or transmission of the RAS oncogene in the Transwell experiments ( Supplementary Fig. S3c ).
To confirm that factors secreted by senescent cells were sufficient to induce paracrine senescence, we exposed normal IMR90 cells to conditioned medium (CM) from IMR90 cells expressing active forms of RAS, RAF or MEK. Whereas cells exposed to CM from control cells grew normally, those treated with CM from senescent cultures showed reduced BrdU incorporation with a higher percentage staining positive for SA-β-galactosidase (SA-β-Gal; Fig. 2d and Supplementary Fig. S3d ). The cell arrest persisted after withdrawal of the CM ( Supplementary  Fig. S3e ). Similar results were observed on mouse embryo fibroblasts ( Supplementary Fig. S3f ).
As paracrine senescence seemed dependent on soluble factors, we reasoned that its effects should be spatially restricted. To investigate this, we seeded a cluster of IMR90 ER:RAS cells surrounded by normal IMR90 mCherry cells (Fig. 2e) . Normal IMR90 Cherry cells in close proximity to the IMR90 ER:RAS cluster (in 3 optical fields, equivalent to up to 1 mm) showed reduced incorporation of BrdU following induction of OIS (Fig. 2e) . In contrast, normal IMR90 Cherry cells located further (>1 mm) from the cluster were unaffected by RAS activation. Similarly, although CM from cells undergoing OIS (primary senescence) triggered paracrine senescence (secondary), CM derived from those cells just slowed down the proliferation of normal cells (tertiary) without inducing SA-β-Gal+ cells ( Fig. 2f and Supplementary  Fig. S3d ). These data do not exclude that either cell-to-cell contact or the extracellular matrix contributes to paracrine senescence but establish a restricted transmissibility of senescence by soluble factors.
Paracrine senescence resembles a full senescence response
Next we co-cultured IMR90 Cherry and IMR90 ER:RAS cells and monitored the expression of senescence markers and effectors by high content analysis using thoroughly validated antibodies ( Supplementary  Fig. S1c-e) . On activation of RAS, IMR90 ER:RAS cells in the co-cultures exhibited high DNA and oxidative damage and upregulated expression of the CDKIs, p16
INK4a and p21 CIP1 and of IL-8, a component of the SASP (Fig. 3a, top centre) . Normal cells (IMR90 Cherry) in the co-cultures also showed increased levels of oxidative and DNA damage and activation of p16 INK4a , p21 CIP1 and IL-8 expression, suggesting a full transmission of senescence (Fig. 3a, top right) . A similar induction of senescent features was observed in normal cells co-cultured with IMR90 MEK:ER cells undergoing OIS (Supplementary Fig. S4a ).
Global gene expression exposed a high correlation between IMR90 cells undergoing OIS and paracrine senescence ( Fig. 3b and Supplementary Fig. S4b ). Unsupervised hierarchical clustering grouped OIS and paracrine senescence (Fig. 3c ) and a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig. 3d) . In addition, qRT-PCR confirmed that CDK inhibitors and the SASP were induced during paracrine senescence ( Supplementary Fig. S4c and Table S1 ).
To understand whether paracrine senescence is commonly associated with senescence, we compared paracrine senescence and OIS induced by MEK activation 19 , observing a significant overlap of upregulated genes ( Supplementary Fig. S4d ). Moreover, we derived a paracrine senescence signature and used gene set enrichment analysis (GSEA) to interrogate its association with senescence transcriptomes. Different human and mouse cell types undergoing replicative senescence or oncogene-or stress-induced senescence exhibited an enrichment of the paracrine senescence signature (Fig. 3e and Supplementary Fig.  S4e ,f). Amongst them, HMEC cells undergoing OIS expressed key SASP components, suggesting a similar implementation of paracrine senescence ( Supplementary Fig. S4g ). The paracrine senescence signature was also associated with murine pancreatic intraepithelial neoplasias (PanIN) and human SSAs ( Fig. 3e and Supplementary Fig.  S4f ), lesions that are both enriched in senescent cells. To examine whether paracrine senescence depends on the same genetic networks as OIS, we knocked down key effectors of senescence in IMR90 cells and either exposed them to CM of senescent cells or co-cultured them with cells undergoing OIS. These experiments revealed that the paracrine senescence arrest depends on the activation of p16 INK4a , p21 CIP1 and p53 ( Fig. 3f and Supplementary Fig. S4h ).
Multiple components of the SASP mediate paracrine senescence
We next catalogued the secretome of cells undergoing OIS using stable isotope labelling of amino acids in culture (SILAC, Fig. 4a ). Unbiased quantitative proteomics offered several advantages for breadth of coverage and its ability to detect changes in protein expression not apparent from gene expression profiling (Fig. 4b) . Amongst the top hits identified were chemokines, TGF-β family ligands or VEGF ( Fig. 4c and Supplementary Table S2 ). To identify which factors mediate paracrine senescence, we compiled a collection of 78 chemical compounds targeting their receptors or key downstream pathways activated by the SASP (Supplementary Table S3 ). Normal IMR90 cells treated with the drug library were exposed to CM from cells undergoing OIS and BrdU incorporation was assessed 48 h later. Out of the compounds partially impairing the arrest, several targeted the VEGFR2/FLT3, TGFBR1 and CCR2 receptors ( Fig. 4d and Supplementary Table S3 ). These compounds were confirmed to inhibit paracrine senescence in a dose-dependent manner, except the CCR2 inhibitor that exhibited a biphasic effect (Fig. 4e) . By using RNA-mediated interference (RNAi) to knock down the expression of CCR2 or the TGF-β receptors ALK4, ALK5 (also known as TGFBR1) and ALK7, we confirmed their role (Fig. 4f,g ). These results suggest that multiple factors secreted by senescent cells mediate paracrine senescence. G12D/+ TGF-βR1 fl / fl mice. Scale bar, 100 µm. Box plot represents first and third quartiles (n = 5 mice per condition). Inside lines shows median. Whiskers extend to highest or lowest observation. P = 0.0184 for both experiments calculated using a Mann-Whitney test. * P < 0.05; * * P < 0.01; * * * P < 0.001. N.S., not significant. Table S3 ). In addition to the compounds identified as affecting paracrine senescence the autocrine senescence screen showed that inhibition of IL1R signalling also prevented OIS (Fig. 5a and Supplementary Fig. S5a ). The comparison between both screens suggested that TGFBR1 inhibitors had a more pronounced effect on paracrine rather than on autocrine senescence (Fig. 5a) . In fact, although GSEA unveiled an association of TGF-β1 signalling with both OIS and paracrine senescence (Fig. 5b) , most TGF-β-dependent genes were more prominently upregulated during paracrine senescence than OIS (Fig. 5c) .
TGFBR1-type receptors bind multiple TGF-β family ligands 20 . Although TGF-β1 was also induced, other ligands of the TGF-β and BMP branches, including BMP6, BMP2, inhibin A and GDF15, were more acutely upregulated during senescence ( Fig. 5d and Supplementary Fig. S5b ). BMP-like ligands and TGF-β-like ligands signal through activation of different SMAD family members. The phosphorylation of both SMAD2/3 and SMAD1/5 was upregulated in cells undergoing paracrine senescence (Fig. 5e and Supplementary  Fig.S5c ), corroborating the involvement of both branches of TGF-β signalling in senescence. The effect of BMP2 on senescence has been reported 21 and further confirmed by us ( Supplementary  Fig. S5d) . Moreover, combination of blocking antibodies targeting TGF-β1, activin A (a homodimer of inhibin A) or BMP2 partially rescue the arrest observed during paracrine senescence (Fig. 5e) . TGFBR1 inhibitors prevented the phosphorylation of SMAD2/3 ( Fig. 5f and Supplementary Fig. S5e ) and blunted the paracrine senescence arrest (Fig. 5f ). These effects correlated with impaired p15
INK4b and p21 CIP1 induction ( Fig. 5f and Supplementary Fig. S5g ), consistent with previous observations 22 . We next investigated whether TGF-β signalling influences senescence in vivo. We used mice bearing a conditional Pdx1-driven activated Kras allele (KRas G12D ; ref. 23). KRas G12D is a potent oncogene in pancreas, but its tumorigenic properties are restrained by its ability to cause OIS, observed in premalignant PanIN lesions 24 . GSEA showed that TGF-β signalling was associated with these PanIN lesions ( Fig. 5g and  bottom low proliferation and stained positive for SA-β-Gal (Fig. 5g) . The OIS was attenuated in Pdx1-cre Kras G12D / + TGF-βR1 fl / fl lesions (Fig. 5g) .
Importantly, Pdx1-cre Kras G12D / + TGF-βR1 fl / fl mice succumbed to a mixture of pancreatic and skin cancer in less than 3 months, but only a subset of Pdx1-cre Kras G12D / + animals progress to pancreatic cancer, and with latency of over a year 26, 27 .
Activation of the inflammasome controls SASP production
As multiple components of the SASP execute paracrine senescence, we searched for factors coordinating their expression. We screened factors for their ability to induce IL-6 and IL-8, identifying IL-1α as one of the most robust inducers (Supplementary Fig. S6a ). IL-1α signalling has been implicated in regulating IL-6 and IL-8 on senescence 28 . A more thorough analysis identified IL-1α as a potent inducer of multiple SASP components (Fig. 6a,b) . Moreover expression of IL-1α caused a SASP-like response phenocopying cells undergoing OIS (Fig. 6c, left) . Although cells expressing inhibin A or TGF-β induced some SASP components such as IL-8 or CCL2 (Supplementary Fig. S6b ), they did not mimic the SASP (Fig. 6c, centre) . Inhibiting TGFBR1 did not affect the secretome induced by IL-1α (Fig. 6c, right) . In addition, whereas IL-1α inhibition partially prevented induction of IL-8 or CCL2 by TGF-β, the converse was not true (Supplementary Fig. S6b ), suggesting that IL-1 has a more prominent role than TGF-β signalling in controlling the SASP.
GSEA showed that IL-1 signalling was associated with paracrine senescence and OIS both in culture and in vivo (Fig. 6d and Supplementary Fig. S6c,d ). Molecules involved in IL-1 signalling (such as IRAK family kinases) were also induced during OIS (Fig. 6e and Supplementary Fig. S6e ). IL-1α and IL-1β are synthesized as precursors. In particular, pro-IL-1β is inactive until processed by the inflammasome, a multiprotein complex comprising caspase 1 and several adapter molecules 29, 30 . Cells undergoing OIS secreted the processed, mature forms of both IL-1α and IL-1β, suggesting inflammasome activation (Fig. 6f) . Indeed, IMR90 cells undergoing OIS exhibited caspase-1 activity (Fig. 6g, left) . The inflammasome was also activated during OIS in vivo: in Braf V600E -driven murine SSAs (ref. 31 ) and in Kras G12D -driven PanIN lesions (Fig. 6g, centre and  right) . Protein levels of inflammasome components such as caspase 1, ASC (also known as PYCARD) and NLRP3 (but not NLRP1) were upregulated during OIS (Fig. 6h and Supplementary Fig. S6f ) without noticeable changes to their messenger RNA levels ( Supplementary Fig.  S6g ), suggesting protein stabilization. Cells undergoing OIS secreted NLRP3 and caspase 1, a characteristic of caspase-1-dependent unconventional secretion 32 ( Supplementary Fig. S6h ). Finally, treatment with caspase-1 or IL-1R inhibitors, (Fig. 6i and Supplementary Fig.  S6i ) but not TGFBRI inhibitors ( Supplementary Fig. S6j ), blunted the expression of SASP components during OIS, suggesting that activation of the inflammasome was a cause rather than an effect of the SASP.
The inflammasome and IL-1 signalling reinforce senescence
Ectopic IL-1α expression arrested IMR90 cells (Fig. 7a) causing senescence ( Fig. 7b) accompanied by increased oxidative and DNA damage, and induction of p53 and p21 CIP1 ( Fig. 7c and Supplementary Fig. S7a ). Conversely, knockdown of the IL-1 receptor or inflammasome components partially prevented OIS (Fig. 7d) . These results were extended using short interfering RNAs (siRNAs) targeting downstream adapter molecules of the IRAK family ( Supplementary  Fig. S7b-d) . Treatment with caspase-1 inhibitors partially prevented the induction of p21 CIP1 and the cell cycle arrest observed during OIS (Fig. 7e) , but inhibition of IL-1R signalling using either short hairpin RNAs (shRNAs; Fig. 7f and Supplementary Fig. S7e ) or blocking antibodies targeting IL-1α and IL-1β ( Supplementary Fig. S7f ) also affected paracrine senescence.
We next took advantage of a model where OIS is induced in mouse livers through stable, transposon-mediated transfer of oncogenic Nras (Nras G12V ). This model was used to show that senescent hepatocytes undergo immune-mediated clearance (designated senescence surveillance), important for tumour suppression 12 .
Using this model, we tested whether blockade of IL-1 and other SASP components affected hepatocyte senescence. After injection with the Nras G12V transposons, mice were treated daily with the indicated compounds for 12 days (Fig. 7g) . Although the percentage of cells positive for Nras expression was similar 6 days after transduction ( Supplementary  Fig. S7g ), 12 days after injection the percentage was higher in mice treated with either IL-1R inhibitor or a combination of drugs (targeting IL-1R, VEGFR2, CCR2 and TGFBR1), reflecting reduced clearance of senescent hepatocytes by the immune system and/or senescence inhibition. To analyse the effect on senescence we measured p16
Ink4a and p21 Cip1 levels, observing that treatment with IL-1R inhibitor or the drug combination reduced the percentage of senescent hepatocytes (Fig. 7h,i and Supplementary Fig. S7h ). Treatment with IL-1R inhibitor also resulted in a significant percentage of NRas+ cells proliferating ( Supplementary Fig. S7i ). The effect of inhibiting IL-1 was further confirmed using IL-1α-neutralizing antibodies ( Supplementary  Fig. S7j) . Overall, the above results highlight the relevance of IL-1 signalling and SASP regulation for senescence in vivo. 
Paracrine senescence is observed in mouse and human models of OIS in vivo
To investigate whether paracrine senescence occurs in pathophysiologically relevant conditions in vivo, mouse and human models of OIS were analysed. First we revisited the model where OIS is induced in mouse hepatocytes by Nras G12V (ref. 12). The senescent hepatocytes are found surrounded by clusters of immune cells 12 ( Fig. 8a) . We observed that many cells in these clusters stained positive for senescence markers (Fig. 8a) . To confirm these findings, we used keratin 5 (K5)-Sos Egfr wa2/+ transgenic mice 33 . These mice develop papillomas with characteristics of OIS as confirmed by staining for p16 Ink4a and p21 Cip1 within the basal and suprabasal layers of the papilloma (Fig. 8b) . Although there were no senescent cells in the tissue close to normal skin, we observed senescent cells present in the K5− tissue adjacent to the senescent papillomas ( Fig. 8b and  Supplementary Fig. S8a ). Examination of their morphological features Supplementary Table S8. (g-i) Inhibition of IL-1R reduces senescence and immune clearance in vivo. (g) Nras G12V or Nras G12V/D38A transposons and a transposase were co-delivered into mouse livers through hydrodynamic injection. Mice were treated with carrier or drugs for 12 days. (h) Quantification of Nras+ (top), p21
Cip1 + (centre) and p16 Ink4a + (bottom) cells on liver sections. Student's t -test (n = 5 mice per condition): carrier/Nras G12V versus IL1R/Nras G12V , P < 0.0150; carrier/Nras G12V versus inhibitor combination/Nras G12V , P < 0.002; p21: carrier/Nras G12V versus IL1R/Nras G12V , P < 0.0341; carrier/Nras G12V versus inhibitor combination/Nras G12V , P < 0.012; p16: carrier/Nras G12V versus inhibitor combination/Nras G12V , P < 0.01. 1, delivery of Nras G12V/D38A and treatment with vehicle. 2-7, delivery of Nras G12V . Treatments: 2, vehicle; 3, IL1R inhibitor; 4, CCR2 inhibitor; 5, VEGFR2 inhibitor; 6, TGFBR1 inhibitor; 7, combination of the 4 inhibitors. Data are mean ± s.e.m. (i) Representative pictures of haematoxylin and eosin (H&E) and immunohistochemistry for Nras, p21
Cip1 and p16 Ink4a . Scale bar, 100 µm. * P < 0.05; * * P < 0.01; * * * P < 0.001.
identified fibroblasts, lymphocytes and plasma cells, but not cells with epithelial characteristics, amongst the senescent cells in the vicinity of papillomas (Supplementary Fig. S8b) .
Finally, we looked for evidence of paracrine senescence during human tumorigenesis studying SSA. Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS (refs 31,34,35) . Epithelial tissue from human SSAs, but not normal colonic crypts, was positive for senescence markers such as p21
CIP1a and negative for proliferation markers such as Ki67 (Fig. 8c) . SASP components such as CCL2 and IL-6 were induced in SSAs (Fig. 8d and Supplementary Fig. S8c ). 
Analysis of expression data
36 also showed the upregulation of IL-1β and other SASP components in SSA (Supplementary Fig. S8d) . Using automated imaging analysis ( Supplementary Fig. S8e) we measured a significant increase in p21 CIP1a + cells (Fig. 8c ,e, P = 0.03) or p21 CIP1 +/Ki67− stromal cells (P = 4.6×10 −5 ) close to SSAs compared with tissue close to normal colonic crypts. These cells had immune or fibroblast morphology (Supplementary Fig. S8f ). These data suggest that senescence can be transmitted in a non-cell-autonomous fashion in both mouse and human models of OIS in vivo.
DISCUSSION
The SASP can potentiate the tumorigenic properties of cancer cells, recruit the immune system to eliminate premalignant cells 5, 12, 13 or reinforce senescence 3 . Here we add paracrine senescence to the repertoire of functions regulated by the SASP. Paracrine senescence could be relevant in different scenarios in vivo. As well as reinforcing the arrest of a cell undergoing OIS, its secretome could induce arrest on the surrounding epithelium, expanding the senescent footprint of the preneoplastic lesion and promoting their immune clearance. Alternatively, cells undergoing OIS could propagate senescence to the surrounding tissue, as suggested here (Fig. 8) . Other scenarios are possible: therapy-induced senescence influences chemotherapy 37 ; radiation can induce a bystander response 38 , which could be partially explained by paracrine senescence; clearance of senescent cells is also beneficial for age-associated disorders 39 . Therefore, it is worth investigating whether paracrine senescence mediates the deleterious effects of senescent cells on tissue homeostasis.
Not all cells surrounding preneoplastic lesions undergo paracrine senescence. Levels of soluble factors, gradients of their concentration, the susceptibility of different cell types and even whether the cells are dividing or arrested are possible factors influencing which cells undergo paracrine senescence in vivo. The nature of these cells and the functional implications of paracrine senescence remain open questions for future studies. Intriguingly, recent work suggests that tumours have the ability to induce p16
INK4a expression in their surrounding stromal and infiltrated immune cells 40 , similar to what we observed here.
In this study, we identified multiple SASP factors with previously unrecognized roles in controlling senescence, for example TGF-β family members (activin A and GDF15), VEGF, and the chemokines CCL2 and CCL20. Although multiple components of the SASP amplify the response, at least in part by activating NF-κB (refs 41,42) , IL-1α is a key regulator not linked previously with senescence induction 28 . There is a wealth of information on the activation of the inflammasome by infectious agents, but less is known about links with other cellular stresses. The ability of the inflammasome to regulate senescence adds to the pro-and anti-tumour effects of the inflammasome 43 . In conclusion, cells undergoing OIS can transmit paracrine senescence to their neighbours. Here, we identified that paracrine senescence is a complex response regulated by the inflammasome and IL-1 signalling. Understanding the significance and regulation of paracrine senescence may be the first step towards manipulating it for therapeutic benefit.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
METHODS
Chemical compounds and neutralizing antibodies. 4-hydroxytamoxifen (4OHT) was from Sigma. 5-Ac-YVAD-CMK and z-YVAD-FMK (caspase-1 inhibitor II and VI) were from Calbiochem. Chemical compounds and concentrations used are summarized in Supplementary Table S4 . Neutralizing antibodies targeting BMP2, TGF β1, activin A, IL-1α and IL-1β (R&D) were used at 10 µg ml −1 .
Cell culture. HEK293T and IMR90 cells were obtained from the ATCC. Cells were maintained as described previously 45 . HMEC-hTert cells were cultured in mammary epithelial cell growth media (PromoCell). Co-culture of IMR90 and HMEC was carried out in mammary epithelial cell growth media (PromoCell) supplemented with 10% FBS. We used 0.02 µm Anopore cell culture inserts (Nunc-Thermo) for Transwell co-culture experiments. Cell numbers and cell viability were determined using Guava Viacount reagent (Millipore) and a Guava cytometer (Millipore).
Retroviral and lentiviral infection. Retroviral and lentiviral infection were performed as previously described 45, 46 .
Plasmids. pRetroSUPER (pRS) plasmids expressing shRNAs targeting p16
INK4a , p53 or p21 CIP1 and pBABE-Ras V12 pLNC-ER:RAS and pLNC-MEK:ER have been described previously 8 . MSCV-puro-based retroviral plasmid encoding IL-1α was generated by cloning its cDNA from pCMV6 IL-1α (Origene). pGIPZ-based shRNA vectors targeting ALK4, ALK5, ALK7, IL1R1, CASP1, ASC and TP53 were from Sigma.
BrdU incorporation, growth curves, colony formation assays and senescence-associated β-Gal staining. These methods have been described elsewhere 45, 46 .
Conditioned medium. The indicated cells (2 × 10 6 ) were seeded in a 10 cm dish and incubated for 7 days with 200 nM 4OHT in DMEM with 0.5% FBS. After incubation, the conditioned medium (CM) was collected, centrifuged at 5,000g and filtered through a 0.2 µm pore filter. CM was mixed with DMEM 40% FBS in a proportion of 3 to 1 to generate CM containing 10% FBS.
Transfection of siRNAs. IMR90 fibroblasts were reverse-transfected with 30 nM siRNA using a 3.5% solution of HiPerFect transfection reagent (QIAGEN). AllStars scrambled siRNA served as negative controls. For a list of siRNAs, see Supplementary  Table S5 .
Gene expression analysis. RT-qPCR was performed as described previously 47 . Primer sets and TaqMan Gene Expression Assays (Applied Biosystems) used are listed in Supplementary Table S6 .
Microarray analysis. For global gene expression studies, cRNA was hybridized to Human Gene 1.0 ST arrays (Affymetrix). Microarray data processing and analysis was carried out at EMBL. Data were normalized using Robust Multichip Average (RMA) and differentially expressed genes were identified using Linear Models for MicroArrays (LIMMA). A cutoff of a Benjamini-Hochberg false discovery rate <0.05 was used to identify significant genes. All analyses were carried out in R (v2.13.0).
Gene set enrichment analysis. We used gene set enrichment analysis (GSEA; v2.07) to examine the association between gene sets and gene expression. We ranked the genes by log 2 fold-change obtained from LIMMA contrasts. Pre-ranked GSEA was performed using the curated Molecular Signatures Database (v3.0) with a size of 5-1,200 genes (http://www.broadinstitute.org/gsea/msigdb/index.jsp). To define the paracrine senescence signature, genes upregulated >2 fold were chosen.
Immunofluorescence and high content analysis. Immunofluorescence staining was performed as previously described 47 using the antibodies listed in Supplementary Table S7 . Image acquisition was performed using an automated highthroughput microscope (IN Cell Analyser 1000 or 2000, GE Healthcare). High content analysis was performed as described elsewhere 45, 47, 48 . Briefly, two or three fluorescence images corresponding to DAPI, primary antibody/Alexa Fluor 488-secondary antibody and Cherry were acquired for each field using the IN Cell Analyser 1000 or IN Cell Analyser 2000 automated epifluorescence (GE Healthcare). No fewer than 1,000 cells were acquired. High content analysis was performed using the IN Cell Investigator software (v1.7; GE Healthcare). DAPI staining was used to identify cells. The nuclei were then segmented using top-hat segmentation. A collar segmentation routine was set to define cell segments. To determine the cellular expression of the analysed protein or detect the Cherry-labelled cells, the mean intensity of pixels in the reference channel (Alexa Fluor 488 or Cherry) within the specified nuclear region (Object Nuclear Intensity) was measured. Each cell was assigned a nuclear intensity value used to set up a threshold filter. The threshold filter used a histogram for data visualization. To set the filter cutoff, expression in control cells was measured to define the negative population, followed by the analysis of the positive control (Supplementary Fig. S1a) . As a result, the software classified each cell as either positive or negative for the expression of the analysed protein or signal ( Supplementary Fig. S1b ). The mean of the nuclear intensity was routinely analysed with equivalent results. Antibodies used for the analysis were tested (shRNAs or siRNAs) to assess their specificity ( Supplementary Fig. S1c-e) .
Mass spectrometry. This was carried out as described in ref. 49 .
Identification of secreted proteins. To identify secreted proteins, a filtering step was applied using ranks 0 to 3 of the Secreted Protein Database, and the Secreted or SPTM classifications of refs. 50,51. This criterion required proteins to be annotated as either ranks 0 to 2, Secreted, or as both SPTM and rank 0 or 1.
Caspase-1 assay. Fifty micrograms of cell extract or 200 µg of pancreatic or colonic tissue protein extract was incubated with WEHD-AFC substrate for 2 h (cells) or 6 h (tissue) and measured in a microplate reader, excited at 400 nm, fluorescence emission at 505 nm.
Antibody arrays. Human chemokine or human cytokine V arrays (Ray Biotech) were processed and quantified using ImageJ software (NIH).
Western blot analysis. Protein extracts were processed and analysed as previously described 45 .
Experiments with Pdx1-Cre KrasG12D/+ mice. Experiments were performed according to UK Home Office regulations. Mice carrying a conditional Pdx1-Cre KrasG12D/+ allele 23, 52 were intercrossed with mice carrying a conditional knockout ALK5/TGBR1 allele 25 . Sections of formalin-fixed paraffin-embedded mouse pancreas from 6-week-old mice were stained with antibody against Ki67. The total number of Ki67+ cells per PanIN, and the total cells per PanIN, were counted, and the percentage of Ki67+ cells per PanIN was calculated. The mean score for each mouse was calculated and these scores were plotted on a box plot. SA β-Gal staining was carried out on cryosections of pancreas collected from 6-week-old mice and assessed using a histoscore method taking account of both the intensity of staining and the proportion of each PanIN staining. This was calculated using the formula (0 × no staining) + (1 × low intensity) + (2 × high intensity). The mean score for each mouse was calculated and these scores were plotted on a box plot. Five mice of each genotype (3 male and 2 female) were assessed. Statistical significance was assessed using a Mann-Whitney test to compare genotypes.
In vivo hepatocyte senescence experiments. The VEGFR2/Flt3/c-Kit inhibitor (Calbiochem 676500) was dissolved in 2% ethanol, 5% Tween 80, 20% PEG 400 and 73% isotonic NaCl solution and orally applied twice daily at 4 mg kg −1 body weight. The IL1-R antagonist (Calbiochem 407616) was dissolved in isotonic NaCl solution and applied through intraperitoneal injection every second day at 200 mg kg −1 body weight. RS102895 (Sigma R1903), a CCR2 antagonist, was applied through the drinking water at a dose of 10 mg kg −1 d −1 per mouse. From the TGF-β RI kinase inhibitor (Calbiochem 616452), a 3.4 mM stock solution in dimethylsulphoxide (DMSO) was prepared. Twice daily, 100 µl of a 1-10 dilution in PBS was injected subcutaneously. For each inhibitor, four C57bl6 mice and four control animals (age 4-6 weeks, all males) were used. Treatment started at day −2 and continued until day 12. At day 0, hydrodynamic tail vein injection of a transposon-based Nras expression plasmid together with an expression plasmid for the sleeping beauty 13 transposase 12 was performed. At day 12, the animals were euthanized and livers collected. Samples were fixed and subjected to immunohistochemical analysis. Microscopic analyses were performed using an Axio Imager M2 (Zeiss). Five high-power fields were counted on two liver sections from each mouse liver (×200, >200 counted cells per field).
Immunohistochemistry of mouse skin samples. Four-week-old wild-type or K5-Sos Egfr wa2/+ mice (heterozygous for a hypomorphic form of Egfr; ref. 33) were used for the experiments (equal ratios of male and female). Normal skin or papilloma samples were isolated from the tail, fixed overnight in 4% PFA and then embedded in paraffin for immunohistochemical analysis.
Immunohistochemistry of human colon samples. Pseudo-anonymized human FFPE tissue samples from 9 patients with sessile serrated adenomas that were resected endoscopically were provided by the Tissue Bank of the National Center for Tumour Diseases Heidelberg (project no. 841) after approval by the ethics committee (no. 206/2005, Medical Faculty, Heidelberg, Germany). Immunohistochemistry was carried out on 3-µm sections. BRAF-V600E-specific immunohistochemistry DOI: 10.1038/ncb2784 (clone VE1) was performed on an automated immunostainer (Ventana BenchMark XT, Ventana Medical Systems) as previously described 53 . The settings included pretreatment with cell conditioner 1 for 60 min, incubation with undiluted VE1 hybridoma supernatant at 37 • C for 32 min and signal enhancement with the Ventana amplification kit (catalogue number 760-080). For Ki67 (clone MIB-1, Dako, 1:400) and p21WAF1/Cip1 (clone SX118, DAKO, 1:25), antigens were retrieved using alkaline buffer (pH 9, Dako). The Ki67 and p21WAF1/Cip1 staining procedures were performed using the Techmate 500+ automated staining system (Dako) with the avidin-biotin complex method. p21+ and Ki67+ nuclei in the tumour stroma were counted per area using virtual microscopy (Spectrum Version 11.0.0.725, Image scope v11.0.2.725, Aperio Technologies, Vista). For statistical evaluation, the p21 to Ki67 ratio was determined and compared using the non-parametrical Wilcoxon rank sum test.
Statistical data analysis. Significance levels were denoted as: * P ≤ 0.05, * * P ≤ 0.01 and * * * P ≤ 0.001. Sources for statistical data are provided in Supplementary  Table S8 .
Accession numbers. Microarray data have been deposited at the Gene Expression
Omnibus under the accession number GSE41318. Table S1 Gene expression analysis of paracrine senescence Table S2 SILAC experiments to define the senescence secretome. 
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